Abcam PLC (ABCM) Stock
ABCM is no longer traded. Abcam PLC was acquired by Danaher (DHR) on December 6, 2023.
Each ABCM share was exchanged for $24.00 in cash. Prices on this page are historical; the last trade was December 5, 2023 at $23.99.
See Danaher (DHR) stock →Abcam PLC stock price history
ABCM final trading statistics
- Final close
- $23.99
- Final trading day
- Dec 5, 2023
- Market cap at delisting
- $5.52B
- Shares outstanding
- 230.15M
- Final 52-week range
- $12.48 – $25.32
- Avg. volume (final 3 mo.)
- 5,847,595
- All-time high (split-adj.)
- $24.47 · Jun 2023
- All-time low (split-adj.)
- $12.62 · Apr 2023
- Return since IPO
- +21.5%
- Beta
- 0.86
- Book value / share
- $3.14
- Price / book
- 7.64
Abcam PLC annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $361.70M | -$8.5M | $0.00 |
| FY2022 | $315.40M | $4.4M | $0.23 |
| FY2021 | $297.70M | $14.6M | — |
| FY2020 | $260.00M | $12.5M | $0.04 |
| FY2019 | $259.90M | $45.0M | $0.27 |
Last five fiscal years reported before the delisting; fiscal year ending June. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Abcam PLC
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam plc operates as a subsidiary of Danaher Corporation.
Abcam PLC stock FAQ
What happened to Abcam PLC stock?
Abcam PLC was acquired by Danaher (DHR) on December 6, 2023. Shareholders received $24.00 in cash for each share. ABCM stock stopped trading on the Nasdaq, with a final close of $23.99 on December 5, 2023.
What did Abcam PLC shareholders receive?
Each ABCM share was converted into $24.00 in cash. The deal was valued at about $5.7 billion.
Is ABCM stock still trading?
No. ABCM was delisted from the Nasdaq on December 6, 2023 and no longer trades on a U.S. exchange.
What was the last price of ABCM stock?
ABCM closed at $23.99 on its final trading day, December 5, 2023, for a market value of about $5.52B.
What were Abcam PLC's revenue and earnings in its last full fiscal year?
Abcam PLC reported revenue of $361.70M and net income of -$8.5M in fiscal 2023, its last full year as a public company.
When did Abcam PLC go public?
Abcam PLC stock began trading on December 3, 2010.